Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Psychostimulants for cancer-related fatigue.

Breitbart W, Alici Y.

J Natl Compr Canc Netw. 2010 Aug;8(8):933-42. Review.

PMID:
20870637
2.

Update on psychotropic medications for cancer-related fatigue.

Breitbart W, Alici-Evcimen Y.

J Natl Compr Canc Netw. 2007 Nov;5(10):1081-91. Review.

PMID:
18053430
3.
4.

Pharmacologic treatment options for cancer-related fatigue: current state of clinical research.

Breitbart W, Alici Y.

Clin J Oncol Nurs. 2008 Oct;12(5 Suppl):27-36. doi: 10.1188/08.CJON.S2.27-36. Review.

PMID:
18842522
5.

Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis.

Minton O, Richardson A, Sharpe M, Hotopf M, Stone PC.

J Pain Symptom Manage. 2011 Apr;41(4):761-7. doi: 10.1016/j.jpainsymman.2010.06.020. Epub 2011 Jan 20. Review.

PMID:
21251796
6.

A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer.

Auret KA, Schug SA, Bremner AP, Bulsara M.

J Pain Symptom Manage. 2009 Apr;37(4):613-21. doi: 10.1016/j.jpainsymman.2008.03.016. Epub 2008 Sep 14.

PMID:
18790598
7.
8.

Treatment of cancer-related fatigue: an update.

Escalante CP.

Support Care Cancer. 2003 Feb;11(2):79-83. Epub 2002 Oct 31. Review.

PMID:
12560935
9.

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.

Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL.

J Clin Oncol. 2006 May 1;24(13):2073-8.

10.

Treatment for cancer-related fatigue: an update.

Manzullo E, Liu W, Escalante C.

Expert Rev Anticancer Ther. 2003 Feb;3(1):99-106. Review.

PMID:
12597354
11.

Modafinil for the treatment of fatigue in lung cancer: a pilot study.

Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K.

Palliat Med. 2009 Jun;23(4):325-31. doi: 10.1177/0269216309102614. Epub 2009 Mar 6.

PMID:
19270033
12.

Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.

Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C.

J Clin Oncol. 2003 Dec 1;21(23):4439-43.

PMID:
14645434
13.

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.

Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D.

J Pain Symptom Manage. 2009 Nov;38(5):650-62. doi: 10.1016/j.jpainsymman.2009.03.011.

PMID:
19896571
14.

Modafinil: is it ready for prime time?

Prommer E.

J Opioid Manag. 2006 May-Jun;2(3):130-6. Review.

PMID:
17319446
15.

A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.

Minton O, Richardson A, Sharpe M, Hotopf M, Stone P.

J Natl Cancer Inst. 2008 Aug 20;100(16):1155-66. doi: 10.1093/jnci/djn250. Epub 2008 Aug 11. Review.

16.

Psychostimulants in supportive care.

Homsi J, Walsh D, Nelson KA.

Support Care Cancer. 2000 Sep;8(5):385-97. Review.

PMID:
10975688
17.

Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.

Thorpy MJ, Schwartz JR, Kovacevic-Ristanovic R, Hayduk R.

Psychopharmacology (Berl). 2003 Jun;167(4):380-5. Epub 2003 Apr 23.

PMID:
12709775
18.

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.

Sarhill N, Walsh D, Nelson KA, Homsi J, LeGrand S, Davis MP.

Am J Hosp Palliat Care. 2001 May-Jun;18(3):187-92.

PMID:
11406895
19.

Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.

Becker PM, Schwartz JR, Feldman NT, Hughes RJ.

Psychopharmacology (Berl). 2004 Jan;171(2):133-9. Epub 2003 Nov 25.

PMID:
14647965
20.

Pharmacologic treatment of cancer-related fatigue.

Carroll JK, Kohli S, Mustian KM, Roscoe JA, Morrow GR.

Oncologist. 2007;12 Suppl 1:43-51. Review.

Items per page

Supplemental Content

Write to the Help Desk